Jonathan Larkin - Concepedia

Author

Jonathan Larkin

Also Known As

J D Larkin, J Larkin, J. D. Larkin, J. Larkin, J.D. Larkin, Jon Larkin, Jonanthan Larkin, Jonathan D. Larkin, Jonathan Larkin

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

GlaxoSmithKline (United States)State Research Institute Centre for Innovative Medicine Thomas Jefferson University University Medical Center Utrecht University of Oulu

About

Jonathan Larkin is an author at GlaxoSmithKline (United States) specializing in medicine, immunology, and osteoarthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	702
2	Biochemistry	3	3	349
3	Natural Sciences	2	2	263
4	Engineering	1	1	28
5	Biomolecular Engineering	1	1	116

Jonathan Larkin

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
An Orally Active TRPV4 Channel Blocker Prevents and Resolves Pulmonary Edema Induced by Heart Failure Kevin S. Thorneloe, Mui Cheung, Weike Bao, Science Translational Medicine	2012	328
Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT) Hongfeng Deng, Heather P. O’Keefe, Christopher P. Davie, Journal of Medicinal Chemistry Drug TargetComplex MixturesMolecular BiologyChemical BiologyPharmaceutical Chemistry	2012	147
Osteoarthritis endotype discovery via clustering of biochemical marker data Federico Angelini, Paweł Widera, Ali Mobasheri, Annals of the Rheumatic Diseases	2022	139
Direct Activation of Protein Kinase C by 1α,25-Dihydroxyvitamin D3 Simon J. Slater, Mary Beth Kelly, Frank J. Taddeo, Journal of Biological Chemistry	1995	127
Protein Kinase Cα Contains Two Activator Binding Sites That Bind Phorbol Esters and Diacylglycerols with Opposite Affinities Simon J. Slater, Cojen Ho, Mary Beth Kelly, Journal of Biological Chemistry Molecular RegulationBind Phorbol EstersOpposite AffinitiesLow Affinity BindingSignaling Pathway	1996	116
Translational development of an ADAMTS-5 antibody for osteoarthritis disease modification Jonathan Larkin, Tessa Lohr, Louis Elefante, Osteoarthritis and Cartilage	2015	114
Interaction of Alcohols and Anesthetics with Protein Kinase Cα Simon J. Slater, Mary Beth Kelly, Jonathan Larkin, Journal of Biological Chemistry Molecular PharmacologyProteinlipid InteractionSignal TransductionReduced Enzyme ActivityBiochemistry	1997	86
Cohort profile: The Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) study: a 2-year, European, cohort study to describe, validate and predict phenotypes of osteoarthritis using clinical, imaging and biochemical markers E.M. van Helvoort, W.E. van Spil, Mylène P. Jansen, BMJ Open	2020	71
Therapeutic effects of an anti-ADAMTS-5 antibody on joint damage and mechanical allodynia in a murine model of osteoarthritis Rachel E. Miller, Phuong Bich Tran, Shingo Ishihara, Osteoarthritis and Cartilage InflammationMechanical AllodyniaJoint DamageMusculoskeletal ResearchRheumatoid Disorder	2015	70
Synergistic Antiviral Activity of Human Interferon Combinations in the Hepatitis C Virus Replicon System Jonathan Larkin, Ling Jin, Mark W. Farmen, Journal of Interferon & Cytokine Research Synergistic Antiviral ActivityHuman Interferon CombinationsViral HepatitisQuantitative AnalysisImmunology	2003	69

Page 1